Yazar "Batool, Rabia" seçeneğine göre listele

Listeleniyor 1 - 3 / 3
  • Küçük Resim Yok
    Öğe
    Alkaloids in the treatment of gastrointestinal tract cancer
    (Bentham Science Publishers, 2023) Riaz, Ammara; Rasul, Azhar; Batool, Rabia; Kanwal, Lubna; Hussain, Ghulam; Sarfraz, Iqra; Shah, Muhammad Ajmal
    Alkaloids, nitrogen-containing compounds, are found in living organisms ranging from microbes to seed-producing plants all over the world. About more than 20,000 alkaloids have been discovered, mostly occurring in higher plants of the families Ranunculaceae, Papaveraceae, Leguminosae, Loganiaceae and Menispermaceae. These compounds are able to inhibit cancer proliferation, especially gastrointestinal cancer, which constitutes the highest incidence rate all over the world. The most diversified group of phytochemicals, alkaloids offer a mighty series of chemical scaffolds and moieties which can be harnessed to ameliorate the devastating consequences underlying cancer. Gastrointestinal (GIT) cancers constitute the malignancies of esophageal, gastric, pancreatic, colorectal and anal tumors, which possess aberrant metabolic signals giving rise to uncontrolled cell proliferation. These cancers are the most frequent of all cancers and account for the high mortality rates worldwide. Conventional therapeutic options carry the risks like being non-economical as well as they possess severe side effects. Natural products offer a wide spectrum of pharmacological properties which can overcome these risk factors by providing cheaper products and are reliable regarding their bio-safety profiles. Alkaloids can be investigated in detail to investigate their pharmacological potential against GIT cancers. Several alkaloids are known to modulate the cell signaling pathways by inducing cell cycle arrest at G0/G1, S and G2/M phases in addition to being the apoptosis inducers. In addition to that, they are also known to target various metabolic pathways, such as p53, B-catenin, MAPK and PIM3. The chapter intends to investigate the biological as well as pharmacological profiles of various alkaloids with special reference to GIT cancers in order to update scientists and researchers about the pharmaceutical potential of these compounds. © 2023 Bentham Science Publishers. All rights reserved.
  • Küçük Resim Yok
    Öğe
    Ficus benghalensis: A plant with potential pharmacological properties, from tradition to pharmacy
    (Pharmacotherapy Group, 2023) Tahir, Muhammad Mateen; Rasul, Azhar; Riaz, Ammara; Batool, Rabia; Nageen, Bushra; Adnan, Muhammad; Sarfraz, Iqra
    Purpose: To undertake an overview of the potential pharmacological properties of Ficus benghalensisis.Methods: Data were acquired from several online sources, including Scopus, Elsevier Science Direct, PubMed, and Sci-Hub, using the keywords Ficus benghalensis, medicinal plants, anti-oxidant, anti-inflammatory, and anti-cancer.Results: Ficus benghalensis has valuable secondary metabolites including terpenoids, ketones, coumarins, oentacyclic, furocoumarin, flavonols, flavonoids, sterols, esters, carbohydrates, carboxylic acid, and polycyclic aromatic hydrocarbons. Due to its phytochemical profile, it is regarded as a plant with potential pharmacological properties such as anti-diarrheal, anti-inflammatory, anti-cancer, anti-oxidant, anti-bacterial, anti-diabetic, anti-tumor, immunomodulatory, anthelmintic, and anti-angiogenic. This review highlights the phytochemistry, traditional uses and pharmacological potential of Ficus benghalensis.Conclusion: Ficus benghalensis has potentials for treating several ailments. However, further research, including in vivo studies and preclinical trials, is necessary to ascertain its biological and pharmacological uses accurately.
  • Küçük Resim Yok
    Öğe
    Potential Anticancer Properties and Mechanisms of Action of Formononetin
    (Hindawi Ltd, 2019) Jiang, Dongjun; Rasul, Azhar; Batool, Rabia; Sarfraz, Iqra; Hussain, Ghulam; Tahir, Muhammad Mateen; Qin, Tian
    Nature, a vast reservoir of pharmacologically active molecules, has been most promising source of drug leads for the cure of various pathological conditions. Formononetin is one of the bioactive isoflavones isolated from different plants mainly from Trifolium pratense, Glycine max, Sophora flavescens, Pycnanthus angolensis, and Astragalus membranaceus. Formononetin has been well-documented for its anti-inflammatory, anticancer, and antioxidant properties. Recently anticancer activity of formononetin is widely studied. This review aims to highlight the pharmacological potential of formononetin, thus providing an insight of its status in cancer therapeutics. Formononetin fights progression of cancer via inducing apoptosis, arresting cell cycle, and halting metastasis via targeting various pathways which are generally modulated in several cancers. Although reported data acclaims various biological properties of formononetin, further experimentation on mechanism of its action, medicinal chemistry studies, and preclinical investigations are surely needed to figure out full array of its pharmacological and biological potential